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The fundamental mechanisms of mitosis are con-
served throughout evolution in eukaryotes, including
ubiquitin-mediated proteolysis of cell cycle regulators
by the anaphase-promoting complex/cyclosome. The
spindle checkpoint protein Cdc20 activates the an-
aphase-promoting complex/cyclosome in a substrate-
specific manner. It is present in the cytoplasm and con-
centrated in the centrosomes throughout the cell cycle,
accumulates at the kinetochores in metaphase, and is no
longer detected following anaphase. However, it is un-
known whether Cdc20 has the same activities and dis-
tribution during meiosis in male germ cells. We found
that in mice, Cdc20 accumulates in the cytoplasm of
pachytene spermatocytes during meiosis I, is distrib-
uted throughout spermatocytes undergoing meiotic di-
vision, and is present in the cytoplasm of postmeiotic
spermatids. Several proteins bind to and regulate the
function of Cdc20 during mitosis. We identified speriolin
and determined that it is a novel spermatogenic cell-
specific Cdc20-binding protein, is present in the cyto-
plasm, and is concentrated at the centrosomes of sper-
matocytes and spermatids and that a leucine zipper
domain is required to target speriolin to the centro-
some. The seven tandem WD motifs of Cdc20 probably
fold into a seven-blade -propeller structure, and we
determined that they are required for speriolin binding
and for localization of Cdc20 to the centrosomes and
nucleus, suggesting that speriolin might regulate or sta-
bilize the folding of Cdc20 during meiosis in spermato-
genic cells.
The mitotic phase of the cell cycle progresses by the periodic
activation and inactivation of regulatory proteins by phospho-
rylation and dephosphorylation (1) and by their selective de-
struction via the ubiquitin-proteasome pathway (2). The mul-
tiprotein anaphase-promoting complex/cyclosome (APC)1 is the
core regulatory component in this pathway (3), and a substrate-
specific recruiting subunit, either Cdc20 or Cdh1, is essential
for APC activation. Cdc20 is activated early in mitosis and
signals the ubiquitin-mediated destruction of cyclin A, securin,
and other proteins and is then degraded, whereas Cdh1 is
activated during anaphase and telophase to trigger the de-
struction of additional substrates (2).
The location of Cdc20 in somatic cells changes during the cell
cycle. In interphase, it is concentrated in the centrosomes and
distributed diffusely at low levels throughout the nucleus and
cytoplasm. During mitosis, Cdc20 accumulates in the nucleus
in prophase, is concentrated at the kinetochores in metaphase
until all chromosomes are aligned at the metaphase plate, and
is no longer detected after late anaphase (4, 5). The N-terminal
167 amino acids are required for Cdc20 to associate with cen-
trosomes (6), and this region also contains the binding domains
for the spindle checkpoint protein Mad2 and the early mitotic
regulator Emi1 (7–9). Mad2 competes with APC binding to the
N-terminal region of Cdc20 until all kinetochores achieve bipo-
lar attachment to the mitotic spindle, whereas Emi1 prevents
Cdc20 interaction with substrates without inhibiting binding
to the APC (10, 11). Dynein-dependent movement of checkpoint
proteins, including Mad2, from the kinetochores along micro-
tubules to the centrosomes occurs at the time of spindle check-
point silencing in mitosis (12, 13), suggesting that the centro-
somes contribute to this process.
The Cdc20 protein contains seven WD motifs that probably
folds into a seven-blade -propeller closed ring structure (14–
16) held together by interaction of a -strand in the first WD
motif with the last of three -strands of the seventh WD motif.
When the N-terminal or C-terminal -strand is deleted, the
protein assumes a relaxed open form (17, 18). Whereas all
seven of the WD motifs are required for localization of Cdc20 to
the kinetochores and to the spindle apparatus (6), it is unclear
how these processes occur. Furthermore, it remains to be de-
termined how the structure of Cdc20 relates to its ability to
selectively bind substrates or to its subcellular localization,
including concentration at the kinetochores.
A meiotic spindle checkpoint apparently functions in mam-
mals during spermatogenesis (19, 20) as it does during oogen-
esis (21, 22). Disrupting the gene for F box protein -TrCP1, a
ubiquitously expressed substrate-binding subunit of SCF ubiq-
uitin ligase (23) reduced male fertility due to overduplication of
centrosomes, formation of multipolar metaphase spindles, mis-
aligned chromosomes, and accumulation of metaphase I sper-
matocytes (24). These defects were caused in part by the accu-
mulation of Emi1 (25). The meiotic checkpoint appears to be
more stringent during spermatogenesis than oogenesis, be-
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cause 10–25% of all human fetuses have an abnormal number
of chromosomes due mainly (80–90%) to nondisjunction of
chromosomes at maternal metaphase I (26).
These studies focused on the role of the last -strand on the
C-terminal WD motif (WD7-4) in the subcellular localization
of Cdc20 during spermatogenesis. They resulted in the identi-
fication of speriolin, a spermatogenic cell-specific protein that
binds to the WD7-4 domain of Cdc20, suggesting that it reg-
ulates Cdc20 during meiosis in male germ cells.
EXPERIMENTAL PROCEDURES
Yeast Two-hybrid Screening—Yeast two-hybrid screening was per-
formed on 3 million clones of a mouse testis cDNA library (Clontech)
using pAS2WD7 as bait, as described previously (27). Screening, elim-
ination of false positives, and plasmid isolation from triple positive
(-galactosidase and His3 gene expression plus 3-amino-1,2,4-triazole
resistance) clones were performed as recommended by the supplier.
Northern Blotting—A mouse Multiple Tissue Northern (MTNTM)
Blot (Clontech), containing 2 g of poly(A) RNA/lane was probed with
a radiolabeled cDNA fragment. The membrane was analyzed by auto-
radiography at 80 °C using Kodak X-Omat AR x-ray film with an
intensifying screen. The blot was exposed for 12–36 h. Blots were
reused after being stripped by boiling in 0.2% SDS.
Construction of cDNA Plasmids—The cDNA fragments for fusion
protein expression were prepared by PCR using Pfu DNA polymerase
(Stratagene) or LA-Taq DNA polymerase (Takara) and cloned into the
appropriate vectors and then verified by sequencing. For yeast two-
hybrid screening, a cDNA encoding the Cdc20 N-terminal segment
(amino acids 1–185) and C-terminal segment of the seven WD motif
region (amino acids 442–499) was cloned into the pAS2–1 (Clontech)
vector, resulting in pAS2WD7. The cDNA for wild-type or mutant
Cdc20 was subcloned into pEYFP-C1 (Clontech) or pFLAG-CMV2
(Sigma) vector to add in-frame N-terminal tags.
To obtain the full-length Sprn cDNA, the 5-rapid amplification of
cDNA ends reaction was performed using mouse testis Marathon-
Ready cDNA (Clontech) as template. The amplified fragment was
cloned into pBluescript KS() vector and sequenced. Wild-type and
mutant speriolin constructs were subcloned into pEYFP-C1 (Clontech)
or pET-28a() (Novagen) vector to add in-frame N-terminal tags.
PCR-based random mutagenesis was performed in the presence of
0.5 mM MnCl2, 1 mM dATP, 1 mM dTTP, 0.2 mM dCTP, and 0.2 mM
dGTP using Taq DNA polymerase (Invitrogen). To produce mutations
in pAS2WD7, the region encoding amino acids 442–499 of Cdc20 was
replaced by randomly mutagenized cDNA fragments encoding the same
region and verified by sequencing. 10 of 4,000 colonies were chosen
randomly for sequencing to estimate the frequency of random mutagen-
esis. 8 of 10 had one or two mutations, and two were wild-type. Plasmids
were extracted from four thousand transformants and pooled to produce
a randomly mutagenized minilibrary (pAS2WD7mut). For speriolin
(amino acids 227–480), cDNA fragments randomly mutagenized by
PCR were subcloned into the pGAD10 (Clontech) vector and verified by
sequencing.
Antibodies—The antibodies to speriolin were raised in rabbits
against a purified His-tagged region of speriolin (amino acids 227–480),
or a synthetic peptide (CRKTPHRKSNKLPDNPRDTK) corresponding
to residues 309–327, conjugated via its amino-terminal cysteine was
conjugated to keyhole limpet hemocyanin. Speriolin (residues 227–480)
with a His6 tag was expressed in BL21 cells, purified by nickel-nitrilo-
triacetic acid-agarose (Qiagen) chromatography, and further purified by
extraction from a single SDS-PAGE band. The antibodies were affinity-
purified by passing crude antiserum over a SulfoLink column (Pierce),
to which the antigen had been coupled. Antibodies were eluted with 0.1
M glycine (pH 2.8) into tubes containing 1 M Tris-base. The pH of the
pooled fractions was adjusted to neutral, and 0.1% NaN3 was added,
and the purified antisera were stored at 4 °C. The specificity of the
antibodies for speriolin was determined by Western blotting using
COS-7 cell lysates containing EYFP-speriolin.
Monoclonal antibody (JL-8) specific for green fluorescent protein
(GFP) and enhanced yellow-green fluorescent protein (EYFP) (anti-
GFP) was from Clontech. Mouse monoclonal antibodies to FLAG (M2),
-tubulin (B5-1-2), -tubulin (GTU-88), horseradish peroxidase-conju-
gated antibody to mouse IgG, and fluorescein 5-isothiocyanate-conju-
gated antibody to rabbit IgG were from Sigma. Alexa Fluor 546-conju-
gated antibody to mouse IgG was from Molecular Probes, Inc. (Eugene,
OR). Antibodies to HSP70/HSC70 (BB70) and calreticulin (SPA-600)
were from Stressgen. Monoclonal antibodies to p55CDC/Cdc20 (H-7)
and Cdc27 (C4), rabbit polyclonal antibody to lamin B (M-20), and
horseradish peroxidase-conjugated goat antibody to rabbit IgG were
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Monoclonal
antibody to pericentrin (clone 30) was from BD Transduction
Laboratories.
Preparation of Mouse Tissue Extracts and Western Blotting—Various
adult tissue samples from CD-1 mice were placed on ice in TN4D buffer
(50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 50 mM NaF, 1 mM Na3VO4,
0.1% Nonidet P-40, 1 mM dithiothreitol, 10% glycerol, complete EDTA-
free protease inhibitor tablet (Roche Applied Science)). Tissues were
homogenized on ice, and then soluble and insoluble proteins were
fractionated by centrifugation at 15,000  g for 30 min at 4 °C. Protein
concentrations were determined using a Bio-Rad protein assay kit II,
and aliquots were stored at 80 °C. Whole cell extracts of fractionated
germ cells or sperm were prepared by boiling cells in SDS sample buffer
for 10 min. Equal loads of proteins from tissue lysates (30 g/lane) were
separated on 10% SDS-polyacrylamide gels and then electroblotted onto
Immobilon membrane (Millipore Corp.). Antigen-antibody complexes
were detected by ECL (Amersham Biosciences). Animal care and use
were in accordance with United States Public Health Service guide-
lines, and procedures used in these studies involving animals were
approved by the Institutional Animal Care and Use Committee of the
National Institute of Environmental Health Sciences.
Cell Culture and Transient Transfection—COS-7 or BALB/3T3 cells
were grown in Dulbecco’s modified Eagle’s medium supplemented with
10% fetal calf serum, 2 mM glutamine, 100 units/ml penicillin, and 100
g/ml streptomycin sulfate. Cells were incubated in 5% CO2 and 95%
air at 37 °C. For transfection, plasmids were prepared with the End-
oFree Plasmid Maxi Kit (Qiagen). Transient transfections were carried
out with TransIt-LT1 (Mirus) according to the manufacturer’s protocol.
For fluorescence microscopic observation, transfected cells were
maintained in 2- or 4-well chamber slides (Lab-Tech) for 24 h at 37 °C.
After washing with phosphate-buffered saline (PBS), cells were fixed
with 4% paraformaldehyde in PBS, and then immunofluorescence
staining was performed. For visualization of nuclei, cells were counter-
stained with 4,6-diamidino-2-phenylindole (DAPI; Sigma).
Immunoprecipitation and Pull-down Assay—For immunoprecipita-
tion, cells transfected with FLAG- and EYFP-tagged proteins were
lysed in TN4D buffer by sonication and cleared by centrifugation at
15,000  g for 30 min at 4 °C. Lysates were immunoprecipitated using
anti-FLAG M2 affinity gel (Sigma) in immunoprecipitation buffer (50
mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.4 mM dithiothreitol, 19 mM NaF,
37 M Na3VO4, 0.037% Nonidet P-40, 10% glycerol) containing freshly
added protease inhibitors (complete EDTA-free protease inhibitor tab-
lets; Roche Applied Science) for 2 h at 4 °C on a rotating platform.
Immunoprecipitates were washed with PBS, boiled in SDS-sample
buffer (65 mM Tris-HCl (pH 6.8), 2.5% -mercaptoethanol, 10% glycerol,
2% SDS, 0.07% bromphenol blue), subjected to 10% SDS-PAGE, and
then electrotransferred onto an Immobilon membrane.
For pull-down assay, GST-speriolin (residues 227–480) bound to
glutathione-agarose (Sigma) was used as bait. GST bound to glutathi-
one-agarose was used as negative control. Adult CD-1 mouse testis was
homogenized in SDS lysis buffer (0.1% SDS, 1% Nonidet P-40, 150 mM
NaCl, 0.5% deoxycholate, 50 mM Tris-HCl (pH 7.4), 10% glycerol, and
protease inhibitor tablet (Roche Applied Science)). The soluble fraction
was diluted to 10 times the original volume in PBS containing protease
inhibitors, mixed with bait, and then rotated for 2 h at 4 °C. After
washing the pellet three times with PBS, proteins were eluted using
SDS sample buffer and then subjected to SDS-PAGE and Western
blotting. Membrane was then stained by Coomassie Blue (Bio-Rad).
Immunostaining of Testis Sections—Immunohistochemical localiza-
tion was carried out on 6-m sections of paraffin-embedded tissue
samples using a Vectastain ABC kit (Vector). The slides were incubated
overnight at 4 °C with primary antibodies, diluted with automation
buffer (Biomeda Corp.) containing 1% bovine serum albumin (BA-
buffer), in a humidified chamber. Monoclonal antibody to Cdc20 (H-7)
was diluted 1:100, and antiserum to speriolin was diluted 1:2000 with
BA-buffer. Slides were stained with 3,3-diaminobenzidine and coun-
terstained with hematoxylin (Vector).
Immunofluorescence Staining of Isolated Germ Cells—Mixed germ
cells were isolated from testes of adult CD-1 mice, with minor modifi-
cations of established procedures (28). Seminiferous tubules were dis-
sociated in enriched Krebs-Ringer bicarbonate medium containing col-
lagenase (0.5 mg/ml) and trypsin (0.25 mg/ml). Following filtration
through 80-m nylon mesh and centrifugation, cells were suspended in
enriched Krebs-Ringer bicarbonate to a final concentration of 106/ml
and transferred onto a SuperFrost plus microscope slide (Fisher). Cells
were fixed with 4% paraformaldehyde/PBS for 10 min, permeabilized
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with 0.5% Triton X-100 for 5 min at 4 °C, and then blocked with 5%
normal goat serum in BA-buffer. Cells were labeled for 2 h at room
temperature with primary antibodies followed by fluorescein 5-isothio-
cyanate-conjugated or Alexa-Fluor 546-conjugated secondary antibod-
ies in a humidified chamber. Nuclei were labeled with DAPI, and slides
were mounted with Vectashield (Vector). Protein localization was de-
termined at a magnification of 400 using a Zeiss Axioplan fluores-
cence microscope and a SPOT digital camera (Diagnostic Instruments,
Inc.). Final images were prepared using Adobe Photoshop Version 6.
Fractionation of Cell Lysates and Trypsin Protection Assay—Tran-
siently transfected COS-7 cells were lysed and homogenized using a
Potter-type homogenizer in Buffer A (50 mM Tris-HCl (pH 8), 0.32 M
sucrose, 1 mM EDTA, 1 mM -mercaptoethanol, complete EDTA-free
protease inhibitor tablet (Roche Applied Science)) and then centrifuged
at 14,000  g for 30 min. The resulting supernatant was further
centrifuged at 100,000  g for 1 h to separate the soluble cytosolic
fraction (100S) from the insoluble particulate fraction (100P). The 100P
pellet was suspended in TN4D containing 1% Nonidet P-40 and 0.5 M
NaCl or in PBS containing 1 mM EDTA (PBSE) for Western blotting or
trypsin protection assays, respectively. Equal amounts of protein were
analyzed by Western blotting.
Four microliters of the 100P pellet obtained from lysates of COS-7
cells expressing EYFP-speriolin were resuspended in PBSE and mixed
with 1 l of 0.25% trypsin-EDTA (Invitrogen) or PBSE and incubated at
37 °C for 5 or 10 min. The reaction was stopped by adding 5 l of 2
SDS sample buffer. Reaction mixtures were analyzed by Western
blotting.
RESULTS
Presence of Cdc20 in Spermatogenic Cells—Northern and
Western blotting of gels loaded with equal amounts of materi-
als determined that Cdc20 mRNA (Fig. 1A) and protein (Fig.
1B) are abundant in the adult mouse testis and that Cdc20
protein is detected in the 0.1% Nonidet P-40-insoluble fraction
of the tissue examined only in testis. The first wave of sper-
matogenesis in postnatal mice is relatively synchronous. The
insoluble form slightly increased in amount on postnatal day
18, corresponding to the first wave of meiotic divisions, and
again on postnatal day 24, when condensing spermatids are
first observed (Fig. 1C). Although this suggested that Cdc20 is
present in spermatids, it was undetectable in sperm isolated
from the cauda epididymis (data not shown). The presence of
Cdc20 in spermatogenic cells was confirmed by immunohisto-
chemistry on sections of adult mouse testis. The protein was
present at low levels in spermatogonia, detected at higher
levels throughout the cytoplasm of midpachytene spermato-
cytes, and localized at the periphery of the nucleus of late
pachytene spermatocytes. The Cdc20 protein was seen
throughout the cytoplasm of spermatids during most of the
postmeiotic phase of spermatogenesis but not in early elongat-
ing spermatids (Fig. 2). The presence of Cdc20 in spermatids
was unanticipated, because in somatic cells it peaks in abun-
dance at the G2/M phase and disappears in late mitosis (29).
Molecular Cloning of Speriolin—Because Cdc20-binding pro-
teins regulate its function during mitosis, we hypothesized that
novel proteins might be involved in regulating Cdc20 function
during meiosis in spermatogenic cells. To identify a Cdc20-
binding protein, a mouse testis library was screened using the
yeast two-hybrid method. Screening with the full-length Cdc20
protein resulted in a large number of false positives. Therefore,
a bait vector (pAS2WD7) was constructed with a cDNA encod-
ing the N-terminal 185 amino acids (containing WD1-1) and
the C-terminal 57 amino acids (containing WD7-2, -3, and
-4) of Cdc20 that was expected to express a WD motif with
four  strands as a GAL4-BP fusion protein (Cdc20-WD).
Empty vector was used as a control. This led to the isolation of
three clones, and sequencing determined that their cDNA in-
serts varied in length but encoded the same protein. A full-
length cDNA was assembled from the overlapping sequences of
the original clones (nucleotides 109–1607), and a fragment was
generated using the 5-rapid amplification of cDNA ends pro-
FIG. 1. Expression of Cdc20 in testis. A, Northern blot analysis of mouse tissue mRNAs. Cdc20 mRNA is abundant in whole testis. B, 0.1%
Nonidet P-40-soluble and -insoluble tissue extracts from adult mouse tissues were separated by 10% SDS-PAGE followed by Western blotting with
a monoclonal antibody to Cdc20 (top panel). Antibodies to HSP70/HSC70 and lamin B were used as loading controls (bottom two panels). Cdc20
was detected in the testis soluble and insoluble fractions. T, adult testis; Ki, kidney; M, skeletal muscle; Li, liver; Lu, lung; Sp, spleen; Br, brain;
H, heart; Th, thymus. C, Cdc20 expression in testis is regulated developmentally. Extracts were prepared from testes of wild type juvenile mice
on postnatal days 14, 16, 18, 20, 22, 24, 26, and 28 and from testes of adult (Ad) mice, as indicated. 0.1% Nonidet P-40-soluble (upper two panels)
and -insoluble (lower two panels) tissue extracts were subjected to Western blotting for the proteins indicated on the right.
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cedure (nucleotides 1–630). An open reading frame between
nucleotides 72 and 1514 encoded a novel protein containing 480
amino acids with a leucine zipper (LZ) motif at the N terminus
(amino acids 3–37), a calculated molecular mass of 51,400
daltons, and a predicted pI of 8.16. We named the protein
speriolin (SPRN). We confirmed physical interaction between
speriolin and Cdc20 by pull-down assays using testis lysates
(Fig. 3). We also found that speriolin co-precipitated Cdc27
(Fig. 3), a component of APC, together with Cdc20, suggesting
that speriolin binds to APCCdc20 in testis. Data base searching
determined that an uncharacterized sequence in GenBankTM is
identical to nucleotides 14–1592 of the Sprn cDNA (accession
number AK006994; RIKEN clone 1700084J23, Mus musculus
adult male testis). It also was determined that the Sprn gene is
located within the WGS supercontig Mm15_WIFeb01_286
(genomic contig: NW_000106) and spans a region of 23.8 kb
located on mouse chromosome 15D3 that is syntenic with hu-
man chromosome 8q24. The gene contains five exons, and the
proposed exon-intron boundaries follow the canonical GT/AG
rule (data not shown). The Sprn cDNA sequence was deposited
in GenBankTM (accession number AB032199). A scan of the
NCBI mouse genome data base using BLAST did not detect any
Sprn pseudogenes.
Speriolin Expression and Localization—Northern analysis
determined that among the mouse tissues examined, the Sprn
message is specific to the testis (Fig. 4A). Speriolin protein also
was detected only in testis homogenates by Western blotting
using either affinity-purified rabbit antisera to His6-tagged
fusion protein (amino acids 227–480) (Fig. 4B) or to a synthetic
peptide (amino acids 309–327) (data not shown). The preim-
mune serum (data not shown) and the antisera preabsorbed
with His-tagged speriolin were negative on testis (Fig. 4B),
providing evidence that the antisera are specific to endogenous
speriolin. Whereas Cdc20 was found primarily in the 0.1%
Nonidet P-40-soluble fraction and in limited amounts in the
insoluble fraction of testis homogenates by Western blotting,
speriolin was detected only in the insoluble fraction (Fig. 4C).
Western blotting of developmental stages of testis further in-
dicated that expression of speriolin begins between days 14 and
16, when pachytene spermatocytes develop, increases by day
22, when postmeiotic spermatids are seen, and is abundant in
epididymal sperm but is not detected in adult ovary (Fig. 4D).
These observations were consistent with the immuno-
histochemical analysis. Speriolin is first seen in late pachytene
spermatocytes, is abundant throughout spermatocytes under-
going meiotic division, and is present in the cytoplasm of
spermatids (Fig. 5).
Immunofluorescence assays on mixed spermatogenic cells
isolated from adult mouse testis were used to determine the
subcellular distribution of speriolin (Fig. 6). The cytoplasm was
weakly stained, but one or two spots in the cytoplasm were
more intensely stained in pachytene spermatocytes, spermato-
cytes undergoing meiotic division, round spermatids, and con-
densed spermatids, suggesting that speriolin accumulates in
the centrosome. This was confirmed by immunostaining of
isolated germ cells simultaneously with antibodies to speriolin
and to the centrosomal protein pericentrin and determining
that the two proteins are co-localized in spermatocytes (Fig. 6).
We also confirmed that pericentrin is undetectable in sperma-
tids (30) but found that speriolin was localized to the centro-
somes in these cells. These results strongly suggest that spe-
riolin is a spermatogenic cell-specific centrosomal protein.
The Leucine Zipper Motif Is Required for Localization of
Speriolin to the Centrosome—A series of EYFP-speriolin dele-
FIG. 3. Cdc20 associates with speriolin. Pull-down experiments of
testis lysate were carried out with GST-speriolin (amino acids 227–
480). GST was used as control. Cdc20 and Cdc27 were detected by
Western blotting (upper two panels) followed by Coomassie Blue stain-
ing (bottom panel). A band slightly smaller than Cdc20 (about 53 kDa in
the upper panel) was a nonspecific signal derived from GST-speriolin.
FIG. 2. Immunohistochemical localization of Cdc20 in sections of adult mouse testis. Sections of adult mouse testis were immunostained
with monoclonal antibody to Cdc20. Cdc20 was most abundant in the cytoplasm of pachytene spermatocytes (P). Immunostaining was also detected
in spermatocytes undergoing meiotic division (M) and in round (RS) and condensing (CS) spermatids while undetectable in early elongating
spermatids (ES). Stages of spermatogenesis are indicated in Roman numerals. Bar, 50 m.
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tion mutants were generated to identify the domain responsi-
ble for centrosomal targeting. Recombinant EYFP-speriolin ex-
pressed in BALB/3T3 cells following transient transfection was
localized in one or two spots in the cytoplasm immediately
adjacent to the nucleus (Fig. 7A). This localization was compa-
rable with the subcellular distribution of endogenous speriolin
in spermatogenic cells (Fig. 6), demonstrating that this heter-
ologous cell system could be utilized for analysis of speriolin
localization. Speriolin deletion mutant N76, expressing only
the N-terminal 76 amino acids of speriolin containing the LZ
domain, was localized adjacent to the nucleus in one or more
spots that varied in size between cells, probably due to different
levels of expression. This suggests that the N-terminal leucine
zipper domain has a key role in targeting speriolin to the
centrosome. However, speriolin deletion mutant D, lacking 28
amino acids (residues 426–454) from the C-terminal region
that contains two D-box-like domains (RXXL), was distributed
in a reticular pattern throughout the cytoplasm. Additional
studies will be needed to determine whether this region is
involved directly in centrosomal localization or if the pattern
seen was caused by a change in speriolin conformation due to
the deletion. Speriolin mutant mLZ, in which valines were
substituted for Leu-10, Leu-17, and Leu-24 in the LZ domain,
was located in multiple perinuclear spots (Fig. 7, A and B).
Treating cells with brefeldin A did not alter the distribution of
mLZ, indicating that it was unlikely to be accumulating in the
Golgi apparatus (data not shown). The result with mutant mLZ
provides further evidence that the leucine zipper domain is
involved in targeting speriolin to the centrosome.
Full-length speriolin and deletion mutant N76 colocalized
with the centrosomal protein pericentrin, confirming their as-
sociation with the centrosome. An unexpected finding was that
pericentrin colocalized in multiple perinuclear spots with spe-
FIG. 4. Expression of speriolin in
testis. A, speriolin mRNA was detected
only in testis. Mouse tissue mRNA blot
used in Fig. 1A was probed with speriolin
cDNA. B, antibody to speriolin detected a
53-kDa band in the 0.1% Nonidet P-40-
insoluble fraction (P) of testis lysate,
whereas speriolin was undetectable in the
soluble fraction (S) of testis lysate. Spe-
riolin was undetectable in testis lysates
using antibody that was preabsorbed by
His-tagged speriolin (right panel). C, 0.1%
Nonidet P-40-soluble and -insoluble tis-
sue extracts from adult mouse tissues, as
indicated in Fig. 1B, were probed with an
affinity-purified antiserum to speriolin. A
53-kDa band was specifically detected in
the testis-insoluble fraction. D, speriolin
expression is developmentally regulated
in testis and abundant in epididymal
sperm. Extracts were prepared from tes-
tes of wild type mice at postnatal day 14,
16, 18, 20, 22, 24, 26, and 28, adult (Ad)
testes, sperm from cauda epididymis, and
soluble (S) and insoluble (P) fractions
from adult mouse ovary, as indicated.
0.1% Nonidet P-40-insoluble tissue ex-
tracts were subjected to Western blotting
with antiserum to speriolin (top panel).
Immunostaining for -tubulin (lower
panel) was used as a loading control for
testis extracts and negative control for
epididymal sperm extracts, respectively.
Immunostaining for HSP70/HSC70 was
used as a loading control for sperm and
ovary extracts.
FIG. 5. Immunohistochemical localization of speriolin in tes-
tis. Histological sections of Bouin’s fixed and paraffin-embedded adult
mouse testis were incubated with affinity-purified antibody to speriolin.
Speriolin was detected in spermatocytes undergoing meiotic division
(M). Staining was detected in pachytene spermatocytes (P) and round
spermatids (RS) and was abundant in the cytoplasm of condensing
spermatids (CS). Bar, 25 m.
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riolin mutant mLZ, suggesting that the association between
speriolin and pericentrin is LZ domain-independent. However,
the amount of pericentrin appeared to increase in the presence
of mLZ (Fig. 7A), suggesting that the speriolin LZ domain is
involved in pericentrin turnover. As controls for these experi-
ments, an antibody to -tubulin was used to verify that the
cytoskeleton was not disrupted by the expression of either
EYFP alone or the EYFP-tagged mutant speriolin proteins
(Fig. 7B). In addition, Western blotting with an antibody to
GFP verified that the mutant speriolin proteins were intact
(data not shown).
Subcellular Distribution of Speriolin—We examined the dis-
tribution of EYFP-speriolin in cell fractions separated by dif-
ferential centrifugation to determine its association with other
cellular components. The low speed supernatant (12,000  g) of
homogenates of COS-7 cells expressing full-length and deletion
mutants of EYFP-speriolin were further separated by centrif-
ugation at high speed (100,000  g) into cytosolic (100S) and
microsomal fractions (100P). When equal amounts of protein
from each fraction were subjected to SDS-PAGE and Western
blotting, EYFP-speriolin was detected mainly in the 100P frac-
tion, whereas EYFP-speriolin deletion mutant D was present
in both fractions (Fig. 7C). Because the centrosome is a non-
membranous organelle, we investigated the membrane topol-
ogy of EYFP-speriolin in the 100P fraction by limited trypsin-
digestion analysis. As a control, we monitored endogenous
calreticulin, one of the major Ca2-binding proteins present in
the lumen of the endoplasmic reticulum. A level of trypsin
digestion that did not affect calreticulin was determined by
Western blotting with an antibody to calreticulin. Under the
same conditions, EYFP-speriolin and EYFP-speriolin deletion
mutant D in the P100 fraction were trypsin-sensitive, consist-
ent with speriolin being at the cytoplasmic face of a nonmem-
branous component of the particulate fraction, such as the
centrosome (Fig. 7D).
The localization of speriolin in the centrosome suggested that
it might associate with other centrosomal proteins. We used
co-precipitation assays to examine the association between
FLAG-speriolin and EYFP-tagged -tubulin, ODF1, or ODF2
co-expressed in COS-7 cells. FLAG-speriolin bound to EYFP-
tagged -tubulin (Fig. 8A), but not to ODF1 or ODF2 (data not
shown). The amounts of EYFP--tubulin that co-precipitated
with full-length (amino acids 1–480) or the C-terminal half
(amino acids 285–480) of speriolin appeared to be less than
what co-precipitated with the other speriolin deletion mutants
(containing amino acids 70–480 or 161–480). This suggests
that the region of speriolin containing amino acids 161–284
participates in the interaction with -tubulin and that the LZ
domain of speriolin interferes with -tubulin association. We
also confirmed that -tubulin was recovered as a complex with
GST-speriolin from testis lysate by pull-down experiments
(Fig. 8B). However, it remains to be determined whether the
association between -tubulin with speriolin is direct or
indirect.
The Cdc20-binding Domain on Speriolin—Yeast two-hybrid
analysis using Cdc20-WD and N-terminal and C-terminal de-
letion mutants of speriolin determined that the C-terminal
region of speriolin containing amino acids 283–480 is required
for Cdc20 binding (Fig. 9A). This region was dissected further
using Cdc20 as bait to screen a yeast two-hybrid minilibrary
constructed following introduction of random mutations into
the cDNA encoding the C-terminal half of speriolin. Fourteen
clones were isolated that lacked binding activity, 11 of which
had nonsense mutations and three of which had single or
double amino acid substitutions. All three substitutions
(V305M, K302R/R314Q, and L469P) were located near the ends
of the Cdc20-binding region (Fig. 9A, diamonds). This region
contained no previously identified protein-protein binding se-
quences, suggesting that speriolin-Cdc20 binding is dependent
on secondary structure or on novel binding sequences.
Further analysis of the physical interaction between sperio-
lin and Cdc20 was carried out using co-immunoprecipitation
assays. A series of FLAG-speriolin mutants were co-expressed
with EYFP-Cdc20 in COS-7 cells. EYFP-Cdc20 was co-immu-
FIG. 6. Speriolin is localized at centrosomes in spermatogenic cells. Spermatogenic cells isolated from adult mice were fixed on slides and
stained with speriolin (green) and pericentrin (red) antibodies and DAPI (blue). Preimmune serum was used as a negative control (bottom panel).
Speriolin and pericentrin were co-localized in pachytene spermatocytes (P) and in cells undergoing meiotic division (M), as indicated by the yellow
signal. Round (RS) or condensing (CS) spermatids were stained only by speriolin (green dots). Bar, 10 m.
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FIG. 7. Subcellular localization of EYFP-speriolin in BALB/3T3 cells. A, centrosomal localization of EYFP-speriolin in BALB/3T3 cells. Vectors
containing full-length Sprn cDNA (wt), the N-terminal 76 amino acids (N76), and a disrupted leucine zipper (mLZ) were transiently transfected into
BALB/3T3 cells. Cells were fixed and stained with monoclonal antibody to pericentrin followed by the Alexa 546-labeled anti-mouse IgG and DAPI
(blue). The subcellular localization of EYFP (bright yellow-green) and pericentrin (red) were viewed by fluorescence microscopy. Co-localized signals
appear in yellow. Empty vector was used as control (EYFP). Bar, 10 m. B, cDNAs for full-length Sprn (wt) or mutants with a deletion (amino acids
426–454) in the C-terminal region containing the D-box-like sequence (D), containing only the N-terminal 76 amino acids (N76), or with a disrupted
leucine zipper (mLZ) were inserted into the mammalian expression vector pEYFP-C1 (EYFP). Transiently transfected BALB/3T3 cells were fixed and
stained with monoclonal antibody to -tubulin followed by the Alexa Fluor 546-labeled anti-mouse IgG and DAPI (blue) for DNA. The subcellular
localization of EYFP (bright yellow-green) and -tubulin (red) were viewed by fluorescence microscopy. C, distribution of EYFP-speriolin in fractions of
transiently transfected COS-7 cells. Cells were harvested, disrupted using a Potter-type homogenizer, and then centrifuged at 12,000  g for 10 min
to remove nuclei and mitochondria. The resulting supernatant was further centrifuged at 100,000  g for 1 h to separate the soluble cytosolic fraction
(100S) from the insoluble particulate fraction (100P). Aliquots of fractionated or unfractionated cell extracts (whole) were subjected to 10% SDS-PAGE
and analyzed by Western blotting with monoclonal antibodies to GFP, HSP70/HSC70 (a protein loading control), or antiserum to calreticulin (an
endoplasmic reticulum-resident protein) as indicated. D, limited trypsin digestion assay on EYFP-speriolin in fractions of transiently transfected COS-7
cells. Aliquots of the isolated particulate fraction (100P) were treated with either 0.05% trypsin or PBS containing 1 mM EDTA for 5 or 10 min followed
by 10% SDS-PAGE. Western blotting was performed using antibodies to GFP (upper panel) and calreticulin (lower panel). Untreated 100P fraction was
used as a positive control (Input). These results show that speriolin is exposed on the surface of a particulate component.
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noprecipitated with FLAG-speriolin but not with C-terminal
truncated FLAG-speriolin or FLAG alone (Fig. 9B), providing
additional evidence that Cdc20 binds to a region in the C-
terminal half of speriolin.
The Speriolin-binding Domain on Cdc20—The WD7-4 re-
gion is critical for folding of other -propeller proteins (17, 18)
and was included in the Cdc20 bait used to screen the yeast
two-hybrid library, leading us to hypothesize that this region of
Cdc20 is required for binding to speriolin. This was tested by
introducing random mutations into the WD7-2, -3, and -4
domains of Cdc20. When 35 negative clones (no speriolin bind-
ing) and 15 positive clones were sequenced, 31 of the negative
clones had nonsense mutations between 2 and 3, whereas
the other four contained point mutations in WD7-4 that were
predicted to disrupt the 4 structure (E465V, R468Q, E474K,
and P477T). In contrast, none of the positive clones that bound
to speriolin had mutations that disrupted the 4 structure
(R471L). One of the negative clones contained a mutation that
altered the length of the 4 structure (E465V), suggesting that
this also has a critical role for Cdc20 binding (Fig. 9C).
We used co-immunoprecipitation-Western assays to confirm
the association between speriolin and Cdc20. Cell lysates were
prepared from COS-7 cells co-expressing FLAG-speriolin and
EYFP-tagged mouse Cdc20, p55Cdc (rat ortholog of Cdc20), or
Cdc20 with mutations disrupting the WD7-4 structure
(R468Q/W470G or truncated at amino acid 457). Mouse EYFP-
Cdc20 and rat EYFP-p55Cdc were co-precipitated with FLAG-
speriolin, but EYFP-tagged mutant Cdc20 or EYFP alone were
not (Fig. 9D). This was consistent with the yeast two-hybrid
results (Fig. 9C) and confirmed that physical interaction occurs
between speriolin and Cdc20.
Intracellular Localization of Intact and Mutated Cdc20—
Deletion of either the N-terminal or C-terminal -strands of
WD motifs cause other -propeller proteins to assume a relaxed
open form (17, 18). In addition, the WD repeats are required for
Cdc20 localization to kinetochores (6). This suggests that
Cdc20 is present in the relaxed open form when it accumulates
in the cytoplasm of late pachytene spermatocytes. To examine
this possibility, EYFP-tagged Cdc20 that either was intact, had
point mutations in WD7-4 (R468Q and W470G), or had
WD7-4 deleted (465–474) was expressed in COS-7 cells.
Intact Cdc20 was associated with kinetochores in the nucleus
of some cells (Fig. 10A, wt) and distributed in the cytoplasm of
others (data not shown), consistent with previous reports of
variation in the location of Cdc20 during different stages of the
cell cycle (5, 6). In contrast, Cdc20 with the point mutations or
with WD7-4 deleted failed to localize to the nucleus and ac-
cumulated in a reticular pattern in the cytoplasm (Fig. 10A).
Brefeldin A treatment did not alter the pattern of distribution
(data not shown). Controls demonstrated that EYFP alone was
located predominantly in the nucleus (data not shown) and
confirmed that the mutated proteins were expressed intact
(Fig. 10B).
DISCUSSION
These studies focused on Cdc20 as an approach to gaining a
better understanding of the regulation of meiosis in spermat-
ogenic cells. In the mitotic cell cycle, Cdc20 is present at low
levels throughout the nucleus and cytoplasm, is abundant in
the centrosomes during interphase, accumulates in the nucleus
during prophase, and is concentrated at the kinetochores from
late prophase until late anaphase (4–6, 10). During exit from
mitosis, Cdc20 is replaced by Cdh1 and is degraded by
APCCdh1, which remains active throughout the G1 phase (2).
We found that Cdc20 accumulates in the cytoplasm of late
pachytene spermatocytes during prophase of meiosis I and is
present in cells undergoing meiotic division, similar to what
occurs during mitosis. This pattern of expression suggests that
Cdc20 serves similar purposes during mitosis and meiosis. An
unexpected finding in these studies was that Cdc20 is not
absent after the meiotic divisions but is present in round sper-
matids, not seen in early elongating spermatids, and becomes
abundant again in late elongating spermatids. However, Cdc20
and the APC are suggested to have other roles in addition to
regulation of mitosis (2, 29, 32). Recent studies indicate that
the APCCdh1 might function outside the cell cycle, both in the
degradation of a regulator of transforming growth factor 
signaling (29) and in postmitotic neurons (33). This would be
consistent with Cdc20 having a novel role during the postmei-
otic phase of spermatogenesis in the development or function of
spermatids.
FIG. 8. Association of speriolin with
-tubulin. A, participation of middle re-
gion of speriolin in association with -tu-
bulin. FLAG-tagged speriolin was recov-
ered from lysates of COS-7 cells co-
expressing EYFP--tubulin and FLAG-
tagged mutant speriolin using anti-FLAG
affinity gel. Immunoprecipitants were
separated by SDS-PAGE and subjected to
Western blotting using antibodies to GFP
for detection of EYFP--tubulin (upper
panel) or FLAG (lower panel). Empty vec-
tor (FLAG vector) was used as negative
control. B, recovery of -tubulin from tes-
tis lysates as a complex with GST-sperio-
lin. Pull-down experiments of testis lysate
were carried out as shown in Fig. 3.
Stripped membrane was reprobed with
monoclonal antibody to -tubulin.
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Multiple proteins have been identified that are involved in
regulating Cdc20 substrate binding and APC activation during
mitosis (7–9, 34). In addition, Cdc20/FZY is present in high
molecular weight multiprotein complexes both in association
with and separate from the APC in HeLa cells (31) and Xenopus
egg extracts (9, 35), suggesting that other Cdc20-interacting
proteins remain to be identified. We also found that Cdc20 is
associated with 0.1% Nonidet P-40-insoluble proteins in testis
extracts, whereas it is present in the soluble fraction of tissue
culture cells (4). These observations encouraged us to use yeast
two-hybrid screening to determine whether meiosis-specific
Cdc20-binding proteins are present in spermatogenic cells.
This led to the identification of speriolin, a novel testis-specific
protein that co-expresses with Cdc20, localizes to centrosomes
in spermatocytes and spermatids, and co-localizes with peri-
centrin in pachytene spermatocytes. In addition, FLAG-sperio-
lin co-precipitates from COS-7 lysates with -tubulin, and
EYFP-tagged speriolin co-localizes with pericentrin when
transfected into BALB/3T3 cells. Mutational analysis showed
that the C-terminal region of speriolin is required for Cdc20
binding and that the N-terminal LZ domain is required for
speriolin to accumulate in centrosomes, but not for pericentrin
to co-localize with speriolin or for -tubulin to co-precipitate
with speriolin. The ability of speriolin to bind to Cdc20, localize
in centrosomes with pericentrin, and associate with -tubulin
strongly suggests that it has a meiosis-specific role in centro-
somes. However, it remains to be determined whether speriolin
associates directly or indirectly with pericentrin and -tubulin
in centrosomes.
We have confirmed that speriolin binds to testicular Cdc20
by pull-down assay. In addition, Cdc27 was recovered together
with Cdc20 from testis lysate, suggesting that speriolin is in a
complex with APCCdc20. From co-immunoprecipitation experi-
ments, it is estimated that 10% of Cdc20 is co-precipitated with
FIG. 9. Speriolin binds to C-terminal WD motif of Cdc20. Mouse Speriolin cDNA was isolated in a yeast two-hybrid screen of a mouse
testis-cDNA library using Cdc20 amino acids 1–185 linked to Cdc20 amino acids 442–499 as bait. A, schematic representation of interactions
between Cdc20 and different speriolin mutants. A leucine zipper is present at residues 3–37 of speriolin. Binding () or lack of binding () to Cdc20
are indicated. The diamonds indicate the position of amino acid substitutions. Empty vector was used as a control. B, speriolin binds to Cdc20 in
vitro. FLAG-tagged speriolin was recovered from lysates of COS-7 cells co-expressing EYFP-Cdc20 and FLAG-tagged mutant speriolin using
anti-FLAG affinity gel. Immunoprecipitants were separated by SDS-PAGE and subjected to Western blotting using antibodies to GFP for detection
of EYFP-Cdc20 (upper panel) or FLAG (lower panel). Empty vector (FLAG vector) was used as a negative control. C, Cdc20 in which -strand 4
of the C-terminal WD motif (WD7-4) was disrupted lost the ability to bind to speriolin. The cDNA for speriolin (residues 283–480) was fused to
GAL4-AD, whereas cDNA for Cdc20 was fused to GAL4-BD using the pAS2–1 vector, resulting in pAS2WD7 (Bait). The four predicted  strands
(WD1-1 and WD7-2, -3, and -4) of the seventh propeller motif (shown in Supplemental Fig. S1) are indicated by the arrows. Substituted
residues are underlined and indicated at the left. The relative binding activities of bait to speriolin (residues 283–480) are shown as either  or
. D, the WD7-4 of Cdc20 is required for binding to speriolin. FLAG-tagged speriolin was recovered from COS-7 lysates co-expressing
FLAG-speriolin with EYFP-tagged mutant Cdc20 using anti-FLAG affinity gel. Immunoprecipitants were analyzed as in B.
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Mad2 (10) or APC (36) from mitotic HeLa cells or mitotic
Xenopus egg extract, respectively. On the other hand, from our
pull-down experiments, we estimate that 0.1% of testicular
Cdc20 is recovered by GST-speriolin, as judged by Western
blotting. However, the physical interaction between speriolin
and Cdc20 during spermatogenesis is stage-specific and might
occur in a Cdc20 structure-related manner. If speriolin selec-
tively interacts with Cdc20 only when Cdc20 forms a -propel-
ler structure, the recovery of Cdc20 from testis lysates would be
expected to be lower than that from synchronized mitotic cell
extracts. It should be noted that speriolin is apparently present
in an insoluble complex with APCCdc20 in spermatogenic cells
because speriolin and Cdc20 were detected in the 0.1% Nonidet
P-40-insoluble fraction only in testis for the tissues examined.
Proteins that contain seven WD motifs are able to fold into a
seven-blade -propeller structure by interaction of the first 
strand of the N-terminal WD motif (WD1-1) and the last 
strand of the C-terminal WD motif (WD7-4) (37), and they
assume an open relaxed form if either of these  strands is
deleted (17, 18). It was shown recently that Cdc20 requires the
Mad2/APC-interacting domain (amino acids 1–167) for local-
ization to centrosomes and the N-terminal WD motif for local-
ization to both centrosomes and kinetochores (6). We found
that when glutamine and glycine were substituted for Arg-468
and Trp-470 in WD7-4, Cdc20 was unable to bind speriolin or
to enter the nucleus. These mutations also caused Cdc20 to
form aggregates in the cytoplasm, similar to what was reported
with disruption of folding of another seven-WD motif protein,
the G protein  subunit (38). These results strongly suggest
that Cdc20 needs to fold into a -propeller structure to bind
speriolin and to enter the nucleus and become available for
association with kinetochores.
A hallmark of spermatogenesis is the expression of a sub-
stantial number of spermatogenic cell-specific genes that are
either novel or orthologues of genes expression in somatic cells
and have roles unique to spermatogenic cells (39, 40). In par-
ticular, there are meiosis-related proteins such as cyclin A1
(41), Rec8 (42, 43), and STAG3 (44) that supplant or comple-
ment similar proteins that function in mitosis. Whereas spe-
riolin lacks homology with known Cdc20-binding or mitosis
regulatory proteins that would provide clues about its function
in meiosis, the results of these studies suggest some interesting
possibilities for examination in future studies. One role of
speriolin might be to regulate or stabilize the folding of Cdc20
by binding to WD7-4. EYFP-Cdc20 failed to localize to the
nucleus or to bind speriolin when this domain was deleted or its
structure was disrupted by point mutations. Differences in the
nuclear envelopes of spermatogenic and somatic cells might
require the presence of speriolin for nuclear entry. These dif-
ferences include the presence of spermatogenic cell-specific nu-
clear lamins (45–49) and the attachment of the synaptonemal
complexes at both ends to the thick nuclear lamina lining the
nuclear envelope of spermatocytes (50, 51). The present studies
noted an increase in lamin B in the testis at day 18, coincident
with the beginning of speriolin synthesis. In addition, the pres-
ence of Cdc20 during the postmeiotic phase of spermatogenesis
might be attributable to it being bound by speriolin, thereby
preventing it from being targeted to the APC. Gene targeting
currently is being used to disrupt function of speriolin as an
approach to determining its roles in vivo and following meiosis
in spermatogenic cells.
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